Browse Content

Page 7 of 99
Sort by:
You must be signed in to view content.

Functional Disease of the Gastrointestinal Tract: Is There a Light at the End of the Tunnel?

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Describe the current understanding of functional GI diseases, and discuss future approaches to move from symptom-based therapies to cure.

Presenter: Nicholas J. Talley, MD, MBBS, PhD, MMedSci, FACG

Release Date: 11/16/2016

Event: 2016 ACG Postgraduate Course

CME Value: 0 minutes

Keywords: dyspepsia, belching, nausea, vomiting, rumination syndrome, Rome IV, GERD

HBV -- Natural History and Management

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Discuss the natural history of hepatitis B, HBV serologies, the different immune stages of the disease, and screening recommendations for HCC in patients with HBV.

Presenter: Mitchell L. Shiffman, MD, FACG

Release Date: 3/11/2016

Event: 2015 Nashville Hepatitis School

CME Value: 30 minutes (Expiration Date: 3/11/2019)

Keywords: liver, hepatitis, hepatitis B, HBV, natural history, hepatocellular carcinoma, Hep School, Hepatitis School

HBV -- Treatment

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Explain current recommendations for the treatment of HBV and summarize the use of anti-HBV drugs to minimize transmission risk during pregnancy and to prevent reactivation of occult HBV during immunosuppression.

Presenter: Paul Y. Kwo, MD, FACG

Release Date: 3/11/2016

Event: 2015 Nashville Hepatitis School

CME Value: 30 minutes (Expiration Date: 3/11/2019)

Keywords: hepatitis, hepatitis B, HBV, pregnancy, treatment, Hep School, Hepatitis School

HCV: Epidemiology, Screening, Natural History and Extra-hepatic Manifestations

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Discuss the epidemiology of HCV, screening recommendations, and the natural history of HCV.

Presenter: Bruce A. Luxon, MD, PhD, FACG

Release Date: 3/11/2016

Event: 2015 Nashville Hepatitis School

CME Value: 15 minutes (Expiration Date: 3/11/2019)

Keywords: hepatitis, hepatitis C , HCV, epidemiology, natural history, Hep School, Hepatitis School

HCV -- Assessing the Patient Prior to Treatment: Diagnostic Testing and Staging

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Assess currently available assays used in the diagnosis of hepatitis C and discuss current modalities available for staging fibrosis in patients with HCV.

Presenter: Jorge L. Herrera, MD, MACG

Release Date: 3/11/2016

Event: 2015 Nashville Hepatitis School

CME Value: 45 minutes (Expiration Date: 3/11/2019)

Keywords: liver, hepatitis, hepatitis C , HCV, treatment, fibrosis, Hep School, Hepatitis School

HCV -- Treatment of Genotype 1: Now and in the Future

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Summarize the current and future management options for patients with HCV genotype 1, including patients with cirrhosis.

Presenter: Paul Y. Kwo, MD, FACG

Release Date: 3/11/2016

Event: 2015 Nashville Hepatitis School

CME Value: 30 minutes (Expiration Date: 3/11/2019)

Keywords: genotype 1, hepatitis, hepatitis C , HCV, Hepatitis School, Hep School

HCV -- Treatment of Genotypes 2, 3 and 4: Now and in the Future

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Summarize the current and future management options for patients with HCV genotypes 2, 3 and 4, including cirrhosis.

Presenter: David E. Bernstein, MD, FACG

Release Date: 3/11/2016

Event: 2015 Nashville Hepatitis School

CME Value: 15 minutes (Expiration Date: 3/11/2019)

Keywords: HCV treatment, HCV, hepatitis C , hepatitis, genotype, genotype 2, genotype 3, genotype 4, Hepatitis School, Hep School

HCV -- Retreatment of DAA Failures

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Discuss how to approach patients who have failed HCV treatment with the current DAA therapies and the role viral mutations/resistance may play in this process.

Presenter: Jorge L. Herrera, MD, MACG

Release Date: 3/11/2016

Event: 2015 Nashville Hepatitis School

CME Value: 30 minutes (Expiration Date: 3/11/2019)

Keywords: hepatitis C , hepatitis, treatment, DAA, direct-acting antiviral, Hep School, Hepatitis School

Treatment of Patients with HCV and HIV

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Review the epidemiology and natural history of HCV in patients with HIV and the treatment options available for these patients.

Presenter: Bruce A. Luxon, MD, PhD, FACG

Release Date: 3/11/2016

Event: 2015 Nashville Hepatitis School

CME Value: 15 minutes (Expiration Date: 3/11/2019)

Keywords: treatment, liver, hepatitis C , HCV, HIV, HCV and HIV

Treatment of Patients with Decompensated Cirrhosis and Liver Transplant Recipients

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Discuss HCV treatment in HCV patients with decompensated cirrhosis, which patients should not be treated and how to manage HCV after liver transplantation.

Presenter: Paul Y. Kwo, MD, FACG

Release Date: 3/11/2016

Event: 2015 Nashville Hepatitis School

CME Value: 0 minutes

Keywords: cirrhosis, decompensated, decompensated cirrhosis, liver, liver disease, liver transplant, transplant, Hepatitis School, Hep School